Physician

Jack Lin, MD

According to 2025 Medicare claims, Jack Lin, MD (NPI: 1649383381) practices epileptologists in the Sacramento-Roseville-Folsom, CA market, with the plurality of this provider's patient population coming from Sacramento, CA. This provider's primary affiliated billing organization is REGENTS OF THE UNIV OF CA (NPI: 1356330203; TIN: 680334324) and primary practice location at 95817-2201. Lin is affiliated with the UC Irvine Health Accountable Care Organization (ACO ID: A3799), participating under the MSSP model.

Lin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 105 traditional Medicare patients, billed 301 HCPCS/CPT codes, and received $23,047 in Medicare payments. The top billing code was 95720 (Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional). Part D data shows 494 prescription claims across 47 beneficiaries totaling $389,289 in drug costs, led by Epidiolex (Cannabidiol (Cbd)). Open Payments data shows 2 records totaling $242. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $45,703 to $23,047. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	152	342	$45,703
2016	186	389	$49,486
2017	143	362	$46,653
2018	126	358	$43,368
2019	143	431	$56,158
2020	126	251	$24,443
2021	154	318	$35,138
2022	108	169	$18,792
2023	114	216	$22,569
2024	105	301	$23,047

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	27	411	$274,787
2016	31	474	$282,171
2017	33	459	$254,530
2018	41	546	$281,749
2019	43	648	$401,965
2020	49	835	$677,915
2021	52	875	$788,999
2022	62	549	$455,956
2023	50	365	$366,611
2024	47	494	$389,289

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95720	Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional	29	66	$166
95718	Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional	13	13	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	30	42	$71
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	25	29	$42
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	46	58	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Epidiolex	Cannabidiol (Cbd)	20	600	$229,959
Fycompa	Perampanel	27	658	$42,872
Xcopri	Cenobamate	18	540	$38,195
Nayzilam	Midazolam	18	155	$12,474
Lacosamide	Lacosamide	88	3,113	$12,044

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$242	JAZZ PHARMACEUTICALS INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jack Lin, MD?

Tedicare shows public-source Medicare data for Jack Lin, MD (NPI 1649383381), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jack Lin, MD have ACO affiliation data?

Jack Lin, MD is shown with ACO affiliation data for UC Irvine Health Accountable Care Organization (MSSP, ACO ID A3799).

What billing organization is linked to Jack Lin, MD?

Jack Lin, MD is linked to REGENTS OF THE UNIV OF CA (billing NPI 1356330203) in the available physician profile data.

Does Jack Lin, MD have Open Payments data?

Jack Lin, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.